Category Archives: Cardiovascular

Fixed and Mobile C-arms Global Market Insights and Outlook 2023-2030: Orthopedics Applications Dominate Revenue, Neurosurgery and Cardiovascular Surge with Rapid Growth

Dublin, Aug. 17, 2023 (GLOBE NEWSWIRE) — The “Global Fixed and Mobile C-arms Market 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The global fixed and mobile C-arms market is on an impressive growth trajectory, with an anticipated market size of USD 3.97 billion by 2030, reflecting a robust CAGR of 5.6% from 2023 to […]

New Wegovy trial results are out. Here are our 3 biggest takeaways.

Findings from a new large-scale clinical trial of Novo Nordisk‘s weight-loss drug Wegovy suggest that it may reduce the risk of serious cardiovascular events by 20%. Advisory Board‘s Regina Lohr and Gabriela Marmolejos share their three biggest takeaways from the trial and explain how these findings could impact chronic disease prevention.  Wegovy may reduce the risk […]

CarDS Lab Members Selected as Finalists for 2023 AHA Young Investigator Awards

Evangelos Oikonomou: Elizabeth Barrett-Connor Research Award Evangelos Oikonomou, MD, DPhil, will present his research focused on a strategy to optimize randomized controlled trial enrollment efficiency during the AHA Scientific Sessions Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training. The presentation, “An Explainable Machine Learning-Based Phenomapping Strategy for Adaptive Predictive Enrichment in Randomized Controlled […]

Weight loss drug semaglutide could boost heart health of up to 93M patients in U.S. alone

Overall, the authors calculated that approximately 93 million patients would be eligible for treatment with semaglutide. This could result in approximately 43 million fewer U.S. adults with obesity and a reduction in that population’s total adverse cardiovascular events of up to 1.5 million. Lead author Nathan D. Wong, PhD, a preventive cardiologist and professor with […]

Air pollution raises risk of heart disease-related disability, death

Share on PinterestA recent study shows a correlation between air pollution exposure and cardiovascular events. zxvisual/Getty Images Researchers investigated the effects of air pollution on cardiovascular health. They found that air pollution is linked to higher numbers of years of life lost, deaths, and years spent in disability. The study found a correlation between air […]

Recent study finds that semaglutide medication may benefit 93 million U.S. adults

Estimated 10-year cardiovascular disease risk and projected number of cardiovascular events (in millions) in 10 years without and with semaglutide treatment, among us adults without cardiovascular disease who are overweight or obese. Data adapted from Wong ND et al., Cardiovasc Drug Therapy 2023. Credit: Dr. Nathan Wong, UC Irvine School of Medicine Researchers from the […]

Social Factors Influence Racial Disparities in Cardiovascular Disease Mortality

Jiang He, MD, PhD Credit: Tulane University New research suggests Black Americans experience a more than 2-fold higher risk of dying from cardiovascular disease (CVD) than their White counterparts, despite substantial reductions in nationwide CVD-related mortality.1 The analysis of more than 50,000 adults revealed these racial disparities may be attributed to social factors, including unemployment […]

Study Shows Microplastics Unexpectedly Introduced During Cardiovascular Procedures

Everywhere scientists look for microplastics, they’ve found them — food, water, air, and some parts of the human body. But examinations of our innermost organs that aren’t directly exposed to the environment are still limited. Now, in a pilot study of people who underwent heart surgery, researchers in American Chemical Society’s Environmental Science & Technology report that […]

AI model for HCM, the first of its kind, gains FDA approval

Viz.ai has received a de novo approval from the U.S. Food and Drug Administration (FDA) for its new artificial intelligence (AI) algorithm designed to identify signs of hypertrophic cardiomyopathy (HCM) in routine electrocardiograms (ECGs). Viz HCM, the first AI model specifically crafted with detecting HCM in mind, automatically reviews ECGs as they are performed, alerting […]